β¨ Medicines and Tax Notices
NEW ZEALAND GAZETTE, No. 140
10 OCTOBER 2013
Product:
Ristova
Active Ingredient:
Rituximab 10mg/mL
Dosage Form:
Concentrate for infusion
New Zealand Sponsor:
Roche Products (NZ) Limited
Manufacturers:
Roche Diagnostics GmbH, Mannheim, Germany
F Hoffmann-La Roche Limited, Basel, Switzerland
Genentech Inc, California, United States of America
Dated this 8th day of October 2013.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
(pursuant to delegation given by the Minister of Health on 6 July 2001).
go6564
Inland Revenue
Income Tax Act 2007
Resident Withholding Tax on Interest
Cancelled certificates of exemption for the period 01/07/13 to 30/09/13
[table of cancelled RWT certificate numbers omitted]
Reissued certificates of exemption for the period 01/07/13 to 30/09/13
[table of reissued RWT certificate numbers omitted]
go6561
Next Page →
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of Ristova
π₯ Health & Social Welfare8 October 2013
Medicines, Distribution Consent, Rituximab, Ristova
- Dr Don Mackie, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
π° Resident Withholding Tax on Interest Certificates
π° Finance & RevenueTax, Resident Withholding Tax, Certificates of Exemption
NZ Gazette 2013, No 140